Savient Pharmaceuticals News
Most Popular Savient Pharmaceuticals Story
Gold out, Johnson in as troubled Dendreon aims for a turnaround
In the course of one short year, Dendreon CEO Mitch Gold went from biotech hero to zero as the long-anticipated rollout of the groundbreaking cancer vaccine Provenge stumbled badly out of the gate. Read more...
Latest Headlines
- February 1, 2012
- October 26, 2010
- September 15, 2010
- September 10, 2010
- October 16, 2009
- September 25, 2009
- September 16, 2009
- August 3, 2009
- June 12, 2009
- February 13, 2009
- October 27, 2008
- July 11, 2006
- December 21, 2005
- October 31, 2005
- October 11, 2005
- September 7, 2005
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
